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Abstract
The periplasmic murein (peptidoglycan) sacculus is a giant macromolecule made of glycan strands cross-linked by short peptides completely
surrounding the cytoplasmic membrane to protect the cell from lysis due to its internal osmotic pressure. More than 50 different muropeptides are
released from the sacculus by treatment with a muramidase. Escherichia coli has six murein synthases which enlarge the sacculus by trans-
glycosylation and transpeptidation of lipid II precursor. A set of twelve periplasmic murein hydrolases (autolysins) release murein fragments during
cell growth and division. Recent data on the in vitro murein synthesis activities of the murein synthases and on the interactions between murein
synthases, hydrolases and cell cycle related proteins are being summarized. There are different models for the architecture of murein and for the
incorporation of new precursor into the sacculus. We present a model in which morphogenesis of the rod-shaped E. coli is driven by cytoskeleton
elements competing for the control over the murein synthesis multi-enzyme complexes.
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The essential murein (peptidoglycan) sacculus is located in
the periplasm of Gram-negative bacteria and is a giant, bag-
shaped macromolecule which encases the cytoplasmic mem-
brane to protect the cell from rupture by its internal turgor
(Fig. 1) [1]. Although the discovery of murein lies more than
half a century back we still have to answer fundamental
questions, as illustrated by three examples: (i) When the cell
grows the sacculus is enlarged in such a way that the specific
cell shape (sphere, rod, comma or other) is maintained. During
cell division the newly synthesized septal murein will become
the murein of the hemispherical caps of the daughter cells. The
molecular mechanisms for bacterial cell shape maintenance,
division site selection and septation are poorly understood. (ii)
The chemistry of the sacculus is well known. Murein consists of
glycan strands cross-linked by peptides forming a three-
dimensional net-work structure. However, its peculiar physical
properties made it impossible to determine the molecular
architecture of a sacculus with the presently available
techniques. For example, the orientation of the glycan strands
and the peptides have to be modeled. (iii) The field also suffers
from having only very few available structures of the key
enzymes for murein biosynthesis, the Penicillin-binding
proteins (PBPs). Surprisingly, there is no known crystal
structure for any murein synthase from a Gram-negative
bacterium. Having outlined the major tasks for future research
at the beginning of this review, we will now summarize the
present knowledge on the chemical structure, biophysics and
biosynthesis of murein in Gram-negative bacteria, with an
emphasis on the reactions and interactions of the murein
synthetic enzymes. We will also present models for enlargement
of the murein layer and for the spatial control of mureinFig. 1. Electron micrograph of a sacculus from a dividing E. coli cell (left side). The b
to the sacculus. Bar, 1 μm. The right side shows a model of the murein layer in a sec
perpendicular to the long axis, and the peptides (thin lines) are running in the directionsynthesis. The data described in this review were derived from
studies in E. coli unless otherwise indicated.
2. Chemical composition and fine structure of murein
Murein is a hetero-polymer made of linear glycan strands of
alternating, β1,4-linked N-acetylglucosamine (GlcNAc) and
N-acetylmuramic acid (MurNAc) residues, that are cross-linked
by short peptides [2] (Fig. 2). The terminal residues of the glycan
strands are GlcNAc and 1,6-anhydroMurNAc, which is MurNAc
with an intra-molecular ether-linkage from C-1 to C-6 [3].
Depending on the strain and the growth conditions, about 3–6%
of the murein subunits have a 1,6-anhydroMurNAc residue.
Hence, the average degree of oligomerization of the glycan
strands is about 25 to 40 disaccharide units [4,5]. Isolated murein
glycan strands with up to 30 disaccharide units can be separated
by high-pressure liquid chromatography (HPLC) and these short
glycan strands have an average length of 8.9 disaccharide units
[6]. The long glycan strands with more than 30 disaccharide units
that represent about 25–30% of the total glycan material, have an
average length of about 45 disaccharide units.
The peptides are attached by an amide linkage to the lactyl
group ofMurNAc and they are unusual because they contain rare
D-amino acids. The initial sequence of the newly synthesized
pentapeptide is L-Ala–D-iGlu–m-A2pm–D-Ala–D-Ala, with
the dibasic meso-diaminopimelic acid (m-A2pm) residing at
position 3. The D-Glu residue is linked via its γ-carboxyl group
to the L-center of m-A2pm. Depending on the species and
growth conditions, a fraction of the peptides contains Gly
instead of D-Ala at position 4 or 5. In murein sacculi isolated
from E. coli, the fraction of pentapeptides is very low due to their
rapid proteolytic degradation to tetrapeptides (L-Ala–D-iGlu–
m-A2pm–D-Ala), tripeptides (L-Ala–D-iGlu–m-A2pm) andlack dots are 6-nm gold particles used to visualize an anti-murein antibody bound
tion of approximately 30×30 nm. The glycan strands (zigzag lines) are running
of the long axis of the sacculus. The smallest hexagonal unit is termed ‘tessera’.
Fig. 2. Structures of the murein glycan strands with a terminal 1,6-anhydroMurNAc residue (A), the C6-O-acetyl modification (in bold) at MurNAc (B), the different
peptide side chains and the DD- and LD-cross-links (C), and the attachment of Braun's lipoprotein (D).
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crescentus have a high percentage of pentapeptides in their
murein, apparently due to the low activity of the murein-specific
peptidases [7]. The chemical structure of the basic murein
subunit, the disaccharide pentapeptide, is shared by nearly all
Gram-negative bacteria, including a few rod-shaped Gram-
positive species, for example Bacillus subtilis and Listeria
monocytogenes [2]. In some species, the free carboxyl groups of
D-Glu or m-A2pm (or both) are amidated. Several Gram-
negative species, for example Neisseria meningitidis and Heli-
cobacter pylori, contain a fraction of MurNAc residues carrying
an additional acetyl group at C-6 [8,9] (Fig. 2B)
Themurein lipoprotein (Braun's lipoprotein, Lpp) is one of the
most abundant proteins of E. coli and is anchored to the outer
membrane by its N-terminal lipid residues. About one third of the
Lpp molecules are covalently linked to the murein, firmly
connecting the outer membrane to the murein layer and
contributing to the stability of the cell envelope in Gram-negative
bacteria. Lpp is attached to murein by a peptide bond between the
ε-amino group of its C-terminal Lys residue and the L-carboxyl
group of them-A2pm residue in themurein peptide [10] (Fig. 2D).
An average E. coli cell has a total of about 3×106 disaccharide
peptide subunits in its murein sacculus [11]. Depending on the
strain and growth conditions, between 40 and 60% of the peptides
in the murein of E. coli [5] and other Gram-negative bacteria [12]
are part of cross-links such that a polymeric, net-like murein
structure is formed. Most cross-links are of the DD-type and
formed between the carboxyl group of D-Ala (position 4) of one
peptide and the amino group at the D-center of m-A2pm (position
3) of another peptide (Fig. 2C). A smaller number of LD-cross-links exists between the L-center of m-A2pm of one peptide and
the D-center of m-A2pm of another peptide. Next to dimeric
peptide structures, there are lower fractions of trimeric and
tetrameric structures, that contain three or four cross-linked
peptides [5].
From the analysis of the composition of the murein sacculus it
became clear that it is not homogenous. Murein is composed of
more than 50 different subunits termed muropeptides (disacchar-
ide peptide units) that differ in the length of the peptide chain (di-,
tri-, tetra-, pentapeptide), the presence of either D-Ala or Gly at
positions 4 or 5, the state of cross-linkage (monomer, dimer,
trimer, tetramer), the type of cross-linkage (DD or LD), the
presence of 1,6-anhydroMurNAc residues (from the glycan strand
termini), and the presence of a L-Lys–L-Arg dipeptide (at position
4), which remains after proteolytic digestion of Braun's
lipoprotein [4]. The major muropeptides present in the murein
ofE. coli are the disaccharide tetrapeptidemonomer (N30% of the
total material) and the DD-cross-linked bis-disaccharide tetra-
tetrapeptide dimer (N20% of the total material). The typical
muropeptide composition of E. coli is summarized in Table 1,
although the muropeptide composition of isolated E. coli sacculi
shows some variation depending on the strain, the growth
medium and temperature, and the growth phase. For example, the
fraction of tripeptides and L-Lys–L-Arg containing peptides as
well as the total cross-linkage is increased in sacculi from
stationary cells, as compared to sacculi from exponentially
growing cells. On the other hand, stationary cells have, on
average, shorter glycan strands (Table 1). The changes in murein
structure during transition from exponential to stationary phase
might be the consequence of down-regulation of the large number
Table 1
The muropeptide composition of E. coli KN 126 grown in LB-medium [5]
Muropeptide a Relative molar percentage (%)
Exponential
growth phase
Stationary
growth phase
Di 1.22 1.97
Tri 8.66 11.99
free 80.6 68.2
in DD-cross-links 16.5 25.8
in LD-cross-links 2.9 6.0
TriLysArg 4.98 8.55
free 68.1 39.9
in DD-cross-links 26.6 49.1
in LD-cross-links 5.1 11.0
Tetra 55.91 37.60
free 66.1 54.9
in DD-cross-links 29.8 37.1
in LD-cross-links 4.1 8.1
Penta 0.51 0.27
free 16 19
in DD-cross-links 84 81
Tetra Gly(4) 2.35 6.05
free 73.2 61.7
in DD-cross-links 24.3 31.8
in LD-cross-links 2.6 6.5
Penta Gly(5) 0.17 0.41
free 53 67
in DD-cross-links 47 33
1,6-anhydroMurNAc ends 3.88 5.63
uncross-linked 34.3 20.2
in DD-cross-links 42.5 60.2
in LD-cross-links 23.2 19.6
Monomers 51.52 39.40
Dimers 43.27 50.52
Trimers 5.02 9.85
Tetramers 0.19 0.22
Average glycan strand length 25.8 17.8
(dissaccharide units)
Degree of cross-linkage b 25.12 32.00
DD-cross-links 22.36 26.80
LD-cross-links 2.76 5.20
a Di, GlcNAcMurNAc(dipeptide); Tri, GlcNAcMurNAc(tripeptide); Tetra,
GlcNAcMurNAc(tetrapeptide); Penta, GlcNAcMurNAc(pentapeptide); Gly(4)/
Gly(5), glycine at position 4 or 5 of peptide side chain; LysArg, Lys–Arg residue
from lipoprotein.
b For calculation see reference [4].
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during cessation of growth. In addition, the cell's preparation for
stationary phase might involve strengthening of the cell envelope
by increasing the number of cross-links in the murein and the
number of contacts between the murein layer and the outer
membrane via Braun's lipoprotein. Among Gram-negative
bacteria, there is also some variability in the fine structure of the
murein, in particular with respect to the abundance of the LD-
cross-linkage and the amount of bound lipoprotein [12].
3. Biophysical properties of murein sacculi
Murein sacculi have unique biophysical properties. They can
be isolated intact from cells and visualized by electron
microscopy as empty cell envelopes with the same length anddiameter as a bacterial cell. The typical length of a sacculus
from E. coli is about 2–4 μm and its diameter is about
0.5–1 μm. Compared to these dimensions, the sacculi have a
very small thickness of approximately 6 nm, as determined by
cryo-transmission electron microscopy of frozen-hydrated cell
sections and by atomic force microscopy on isolated sacculi
[13,14]. Isolated sacculi have also been analyzed by small-angle
neutron scattering showing that approximately 75–80% of the
surface of the sacculi have a thickness of 2.5 nm, and the
remaining 20–25% of the surface is maximally 7 nm thick [15].
The murein net is not rigid but it can reversibly expand and
shrink three-fold without rupture [16]. Isolated sacculi are two-
to threefold more deformable in the direction of the long axis of
the cell than in the direction perpendicular to the long axis [14].
In the same study the elastic modulus of hydrated sacculi was
determined as 2.5×107 N/m2. In living bacteria, the surface area
of the murein is 45% larger than that in the same bacteria upon
relaxation of the murein by a sudden destruction of the
cytoplasmic membrane [17]. These data indicate that the murein
forms an elastic net which is expanded to some extend in the
living cell due to the cells turgor pressure.
There are pores with a mean radius of 2.06 nm in the relaxed
sacculi, and it is estimated that globular proteins up to a
molecular weight of 24 kDa should be able to diffuse through the
murein net [18]. However, in the living cell, the expanded
murein might even be permeable for proteins of up to 100 kDa
[19]. Many proteins are transported across the periplasm (and
hence, through the murein net) to become inserted into the outer
membrane. For example, the outer membrane lipoproteins are
transported across the periplasm in a soluble complex with the
chaperone LolA [20], that apparently can diffuse through the
murein layer. On the other hand, the assembly of larger com-
plexes through the periplasm, like flagella, fimbria or complexes
secreting proteins or DNA, seems to require the activity of
specialized murein hydrolases to locally open the meshes of the
murein net [21,22].
4. Models for the architecture of murein
Murein has a heterogeneous, flexible structure and is not
crystalline, making it impossible to directly determine its struc-
ture at high resolution with the presently available techniques.
Molecular modeling suggested that the glycan strands are rather
rigid structures, whereas the peptides are flexible. In the
favorable conformation, a peptide bends back towards the
glycan strand [23]. Under stretched conditions, the peptides
adopt a more straight conformation, allowing the murein net to
become expanded [24,25]. The flexibility of the peptides could
be the reason for the observed elasticity of murein. According to
a model of murein architecture [23,26,27], the peptides protrude
in a helical pattern from the glycan strands, with about four
disaccharide units being required for one complete turn.
Recently, the smallest possible glycan fragment carrying two
peptides has been analyzed by NMR [28]. It was suggested that
the angle between the peptides is about 120 degrees, which
would imply that three peptides are required for one turn. Mono-
layered, net-like structures can be modeled by cross-linking
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from the murein layer (up or down) could not be present in cross-
links which is in accordance with the observation of a large
fraction – about 40–60% – of monomeric peptides being present
in isolated sacculi.
The classical model predicts the glycan strands to be arranged
in parallel to the cytoplasmic membrane and being cross-linked
by the peptides to form a planar murein layer. According to
Koch, the glycan strands are not straight but follow a zigzag line
to form a layer with hexagonal ‘tessera’ as the smallest pores
(Fig. 1) [29,30]. The measured thickness of the sacculi (see
above) led to the conclusion that 75–80% of the surface is single
layered, whereas the rest is triple layered. The anisotropy in
elasticity observed in isolated sacculi might indicate that the
flexible peptides run predominantly in the direction of the long
axis of the rod-shaped E. coli cell, whereas the glycan strands
run predominantly perpendicular to the long axis.
The concept of a layered murein net has recently been
challenged. In the ‘scaffold’ models of murein architecture the
glycan strands protrude vertically from the cytoplasmic
membrane [28,31]. As it has been discussed in a recent review
[32], the scaffoldmodels are not in accordance with the observed
average length of more than 20 disaccharide units of the glycan
strands isolated from E. coli. The glycan strands of average
length are too long for a vertical arrangement in the periplasm.
5. Murein synthesis
Murein biosynthesis takes place in two different cell
compartments: the precursor lipid II is synthesized in the
cytoplasm and then flipped across the cytoplasmic membrane.
The reactions for the enlargement of the murein sacculus occur at
the periplasmic site of the cytoplasmic membrane. An excellent
overview about the murein precursor synthesis is given by van
Heijenoort [33]. Key intermediates of precursor synthesis are the
nucleotide activated amino sugars uridindiphosphate-N-acteyl-
glucosamine (UDP-GlcNAc) and uridindiphosphate-N-acteyl-
muramic acid (UDP-MurNAc). The peptide side chain is formed
at the lactyl group of UDP-MurNAc by the successive additionTable 2
Murein synthases of E. coli a
Protein MW [Da] Gene Domains (region an
site residue b)
PBP1A 94,519 ponA TG: L65 to A266 (E
(mrcA) TP: Q429 to G823 (
PBP1B α 94,292
PBP1B β 91,593 ponB TG: D198 to I385-S
PBP1B γ 88,889 (mrcB) TP: Q477 to M780
PBP1C 86,067 pbpC TG: R64 to I245-M2
TP: Q281 to G598 (
PBP2 70,857 pbpA nPB: R68 to L254
(mrdA) TP: D255 to N617 (
PBP3 63,877 ftsI nPB: R71 to I236
(pbpB) TP: D237 to V577 (
MtgA 27,342 mtgA TG: V67 to D242 (E
a See text for references.
b Active site residues: glutamate in TG domain and serine in TP domain.
c Not determined.of L-Ala, D-Glu, m-A2pm and a D-Ala–D-Ala dipeptide
catalyzed by ATP-dependent ligases MurC, MurD, MurE and
MurF, respectively. The D-amino acids are synthesized by
racemases from the respective L-amino acids.
To facilitate transport of the hydrophilic precursors across the
cytoplasmic membrane, a C55-polyisoprenoid carrier is attached
by MraY to form lipid I, the undecaprenyl pyrophosphoryl-
MurNAc-pentapeptide. Next, GlcNAc (from UDP-GlcNAc) is
added to lipid I byMurG forming the final murein precursor lipid
II. The flippase(s) responsible for the transport of lipid II from
the cytoplasmic to the periplasmic leaflet of the cytoplasmic
membrane is (are) not yet known.
The following sections give an overview on the properties of
the murein synthases and hydrolases from E. coli and on the
recent data on the activities and interactions of the synthases. In
the next sections we then present current models for the
enlargement of the sacculus and for the spatial regulation of
murein synthesis.
6. The E. coli murein synthases
Murein synthases catalyze the enlargement of the sacculus
by incorporation of lipid II precursor. These proteins are present
in 120 to 220 copies per cell [34] and are either monofunctional
transglycosylases, bifunctional transglycosylases/transpepti-
dases or monofunctional transpeptidases (Table 2). All murein
synthases are anchored to the cytoplasmic membrane by a
single transmembrane region close to their N-terminus. They
have a short N-terminal cytoplasmic part while the catalytic
transglycosylation (TG) and transpeptidation (TP) domains are
located in the periplasm (Fig. 3A). Murein synthases containing
a TP activity are known as Penicillin-binding proteins (PBPs)
because of their ability to covalently bind Penicillin and other
β-lactams, which have structural similarity with the D-Ala–D-
Ala termini of the pentapeptide side chains. Depending on the
properties of the non-Penicillin-binding (nPB) motifs they are
divided into two classes. Class A PBPs like PBP1A, PBP1B and
PBP1C of E. coli are bifunctional enzymes harboring a TG
domain as nPB module and a TP domain as Penicillin-bindingd active Intracellular localization Copy number
per cell
94) Cytoplasmic membrane 221±20
S473)
409 (E233) Cytoplasmic membrane,
lateral wall and septation site
127±13
(S510)
63 (E94) Cytoplasmic membrane NDc
S342)
Cytoplasmic membrane,
lateral wall and septation site
120±14
S330)
Cytoplasmic membrane,
septation site
132±17
S307)
84) Cytoplasmic membrane ND
Fig. 3. Schematic representation (A) and sequence motifs (B) of the murein synthases from E. coli.
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conserved amino acids (Fig. 3B). Class A PBPs contain 5 motifs
(motif 1 to 5) within the nPB-module and are connected to the
PB-module via a linker motif (motif A). The PB-module con-
tains a further conserved motif B and the 3 distinct motifs of
the acyltransferases: motif I [S*X2K], harboring the active site
serine (S*) residue, motif II [(S/Y)X(N/C)] and motif III
[(K/H)(T/S)G] (X, any amino acid). Class B PBPs have only 3
conserved motifs within the nPB-module (motif 1′ to 3′), a
linker-motif A′ between the two modules and a PB-module
with motif B′ and the typical acyltransferase motifs I, II and III
[35,36]. It has been proposed that the nPB domain plays a role
in the assembly of class B PBPs in multi-protein complexes
[37,38].
In E. coli the class A PBP1A and PBP1B are considered to
be the enzymes with highest murein synthesis activity in the
cell. Both enzymes are not required for cell growth, but a doubledeletion of the corresponding genes is lethal [39,40]. There is
evidence that both proteins might play distinct roles during cell
growth and division. Mutants lacking PBP1B are more sensitive
to β-lactam antibiotics than mutants without PBP1A [41].
Furthermore, cell integrity is lost upon inactivation of PBP2,
PBP3, or the cell division protein FtsQ, in mutants without
PBP1B, but not in mutants without PBP1A [42]. PBP1A and
PBP1B form homodimers but not heterodimers in vivo, further
indicating that both proteins may have distinct cellular functions
[43,44]. E. coli has a third class A protein, PBP1C, which
cannot substitute for a double loss of function of PBP1A and
PBP1B [45].
The monofunctional transpeptidases PBP2 and PBP3 belong
to the class B PBPs and appear to have specific functions during
the cell cycle. PBP2 is required for cell elongation while PBP3
localizes to mid-cell during septation and is required for cell
division [46]. There is also a monofunctional transglycosylase
1720 W. Vollmer, U. Bertsche / Biochimica et Biophysica Acta 1778 (2008) 1714–1734(glycosyl transferase), MtgA, which shows sequence similarity
to the nPB-module of the class A PBPs sharing the typical motifs
1 to 5.
So far only the C-terminal boundary of the TG-domain of
PBP1B has been experimentally determined by activity assays
using truncated forms of the protein [47]. The other boundaries
of the TG and TP domains of the E. coli murein synthases were
estimated by sequence comparisons (at http://genolist.pasteur.fr/
Colibri/) with either PBP1B or PBP3, for which the boundaries
had been suggested [48,49] (Table 2).
6.1. The Penicillin-binding protein 1A
The bifunctional transglycosylase/transpeptidase PBP1A
[50] is encoded by the ponA (mrcA) gene [51]. Deletion of
ponA has no significant effect on cell growth, morphology or on
the sensitivity of the cell towards β-lactam antibiotics [41]. On
the other hand, deletion of ponB (encoding for PBP1B) leads to a
higher sensitivity of the cells to β-lactam antibiotics. This is
consistent with the observations that PBP1A has a higher affinity
to most β-lactams as compared to PBP1B, and that the
inactivation of both, PBP1A and PBP1B is lethal for the cell
[40,52]. PBP1A contains a transmembrane anchor, presumably
from F15 to I36, and the typical TG- and TP-domains for class A
PBPs [36]. Sequence comparison to PBP1B implies that the TG-
domain reaches from about L65 to A266 followed by a typical
linker region and the TP-domain from about Q429 to G823. The
catalytically active residues in both domains have been shown to
be E94 in motif 1 of the TG-domain and S473 in motif I of the
TP-domain [53].
6.2. The Penicillin-binding protein 1B
The bifunctional PBP1B is encoded by the ponB (mrcB) gene
and exists in three isoforms (α, β, and γ) which differ only in the
length of their short cytoplasmic part and which can be separated
by SDS-gelelectrophoresis. The start codon of the γ-isoform is
identical to the codon for methionine at position 46 of the
α-isoform [51,54,55]. The β-isoform appears to be generated by
an artificial cleavage of PBP1Bα after the N-terminal 25 amino
acids by the outer membrane protease OmpT [56,57]. It is not
clear whether PBP1Bα and PBP1Bγ have different functions
although it was suggested that PBP1Bα could be involved in
murein synthesis during cell division while PBP1Bγ synthesizes
new material for elongation of the murein sacculus [58].
The major part of PBP1B is located in the periplasm. Directly
after the transmembrane region (G64 to D88) there is a region of
about 100 amino acids not present in PBP1A and responsible for
the correct folding of the protein [49]. The TG domain starts at
D198 and contains the five conserved motifs characteristic for
class A PBPs [35]. Homology searching has identified
conserved motifs, which suggest the catalytic residues E233,
D234, and E290 are involved in the catalysis. The exchange of
E233 by Q resulted in the complete loss of enzymatic activity.
Replacement of D234 by N and E290 by Q lead to a reduction in
activity. A protein, in which Y310 was substituted by F was
degraded immediately and could therefore not be purified [49].The C-terminal border of the TG domain has been located
between I385 and S409 [47].
The TP domain lies in the C-terminal part of the protein
(Q447 to M780) and shows three typical motifs of the
penicillinoyl-serine-transferase superfamily. S510 is part of the
catalytical triade and directly involved in the enzymatic reaction.
The C-terminal part from R781 to N844 is dispensable for the
activity of PBP1B [54,59,60].
6.3. The Penicillin-binding protein 1C
The non-essential PBP1C is encoded by the pbpC gene [45].
PBP1C cannot support cell growth in the absence of PBP1A and
PBP1B and could have a specialized cellular function. The
calculated mass of PBP1C of 85,067 kDa differs significantly
from the apparent molecular weight of about 70 kDa observed by
SDS-gel electrophoresis. PBP1C contains a transmembrane
region (presumably G9 to D29). We predict that the transgly-
cosylase domain of PBP1C ranges from R64 to the region
between I245 and M263. Despite the absence of three highly
conserved amino acid residues (R136 and E140 of motif 3, and
R218 of motif 5) in the TG domain, PBP1C is capable of binding
the inhibitor moenomycin and shows transglycosylation activ-
ity. We predict that the transpeptidase domain starts with Q281
and ends with G598, and that it contains the three typical
conserved motifs of class A PBPs, with S342 as the active site
serine. Nevertheless, as compared to other PBPs, PBP1C has
significantly different affinities toβ-lactam antibiotics and binds
virtually only the oxacephalosporin latamoxef and a Bolton/
Hunter derivative of ampicillin [61,62].
6.4. The monofunctional glycosyltransferase MtgA (Mgt)
MtgA is capable of glycan strand polymerization but not of
cross-linking the peptides [63]. The enzyme has a molecular
weight of 27,342 kDa and is similar in sequence to the TG
domain of the class A HMW PBPs. The mtgA gene could
be deleted in several species like E. coli [45], Haemophilus
influenzae [64], and Brucella abortus [65] without severe
growth defects under laboratory conditions. On the other hand,
the mtgA-deletion strain of B. abortus was less virulent in a
mouse infection model [65]. MtgA contains a predicted
transmembrane region from L19 to V39. It was suggested that
the TG-domain reaches from V67 to the end of the protein
(D242) [66]. Experimental data obtained with Staphylococcus
aureus MtgA showed that the strictly conserved residue E100
(corresponding to E84 in MtgA from E. coli) is essential for
catalytic activity.
6.5. The Penicillin-binding protein 2
The monofunctional transpeptidase PBP2, encoded by the
pbpA gene, is essential for cell elongation and maintenance of
the rod shape of E. coli [46,67,68]. From sequence comparisons
of PBP2 with PBP3 we predict that the nPB-domain covers the
region from R68 to L254 and the transpeptidase domain begins
with D255 and ends with N617. Both domains contain the
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same operon as the rodA gene encoding for an integral mem-
brane protein which is (like PBP2) required for the enlargement
of the side wall of the sacculus [69,70]. Inhibition of PBP2 with
mecillinam [67] results in spherical cells with constitutive septal
murein synthesis [71] which are unable to form colonies. The
deletion of pbpA is tolerated in some mecillinam resistant
mutants impaired in the lov and cya genes as well as in mutants
affected in an aminoacyl-tRNA synthetase. It is suggested that
although PBP2 is responsible for murein biosynthesis during cell
elongation it has a second (essential) function in regulation of
septation [72–74]. This is consistent with the observation that
GFP–PBP2 localizes not only at the lateral wall but also at the
site of cell division. The GFP–PBP2 fluorescence signal appears
at mid-cell at the same time as the constrictions gets visible and
disappears just before cell separation. In contrast to cell division
proteins like FtsZ and FtsW, PBP2 does not localize at mid cell
when PBP3 is inactivated by aztreonam. Therefore it was
concluded that PBP2 is not a stable part of the cell division
machinery (divisome) [75]. Mecillinam-treated cells divide for
several generations with an increase in cell diameter until they
lyse, presumably because the cell division protein FtsZ becomes
limited in large spherical cells. This is supported by the
observation that overexpression of the ftsZ gene allows these
cells to perform more divisions [74]. Thus, next to its essential
role for the cell elongation process, PBP2 might have a function
at the initiation of cell division which is essential for maintaining
the cell diameter.
6.6. The Penicillin-binding protein 3
The essential cell division specific PBP3 (also named FtsI) is
a monofunctional transpeptidase of 63,877 kDa and is encoded
by the ftsI gene [46,76]. Cells with a temperature sensitive PBP3
cannot divide at restrictive temperature and grow as filaments
[77] and so do cells in which PBP3 has been specifically
inhibited by aztreonam [78]. Early experiments suggested that
PBP3 might be a bifunctional transglycosylase-transpeptidase
[79]. Sequence comparison and biochemical studies revealed
that the enzyme likely does not have a TG activity but is active as
a monofunctional transpeptidase [48,80,81]. The three-dimen-
sional structure of PBP3 (from R71 to V577) has been modeled
based on the known crystal structure of PBP2x from Strepto-
coccus pneumoniae [48,82].
The N-terminal 23 aa of PBP3 localize in the cytoplasm,
followed by the transmembrane domain (F24 to L39) [83]. The
nPB module (from R71 to I236) contains the three characteristic
motifs 1′, 2′ and 3′, while the TP domain (D237 to V577)
contains the characteristic motifs I, II and III of the SXXK
acyltransferases [35–37,84]. Remarkably, a short 26-amino acid
stretch from W22 to V47 covering the transmembrane region is
sufficient for the correct localization of PBP3 to the cell division
site [85]. The nPB module could be responsible for the correct
folding of the protein as well as for interactions with cell division
proteins like FtsN and FtsW (see below) [48,84,86]. Mutation of
G188, which is the first amino acid of the conserved motif 3′,
affects folding and stability of PBP3 [38]. The 12 C-terminalamino acids of PBP3 are removed by the Prc-protease, resulting
in the mature protein with 577 amino acids [87]. Although the
C-terminal truncation affects the stability of PBP3, the
physiological role of the maturation has remained unclear.
7. Studies on the murein synthesis reactions
7.1. Transglycosylation and transpeptidation reactions
The transglycosylation step in murein synthesis produces the
glycan strands from lipid II substrate. It has been suggested that
the growing glycan strand acts as donor during TG reaction such
that the glycosidic bond is formed between C1 ofMurNAc of the
growing chain and C4 of the GlcNAc residue of the next lipid II
[33,88]. This is supported by two recent publications on the first
known crystal structures of murein transglycosylases, PBP2
from S. aureus [89] and PBP1A from Aquifex aeolicus [90].
Interestingly, both structures do not resemble structures of other
known glycosyl transferases but have striking similarities with
bacteriophage λ-lysozyme. Because transglycosylases utilize a
membrane-bound substrate (lipid II) it is not unexpected that the
structures show hydrophobic surface sites for the interaction
with the membrane. PBP2 from S. aureus was crystallized with
and without the TG-specific inhibitor moenomycin. Lipid II and
the growing glycan chain were modeled into the structure of
PBP2. The lipid II acceptor fits between the glycan chain (donor)
and the catalytic residue E114. A glycan chain of more than two
disaccharide units (not counting the disaccharide of lipid II) can
protrude out of the TG domain without any steric hindrance [89].
The TG-domain of PBP1A of A. aeolicus contains an active site
cleft, which can be covered by a flap. It was possible to model a
growing glycan chain into the cleft with the reacting end
anchored behind the flap and the lipid chain extending past the
hydrophobic patch and into the membrane. The acceptor lipid II
is suggested to bind in the more open site of the cleft with the
GlcNAc moiety directed to the MurNAc of the donor. The flap
prevents the glycan product from dissociation and the elongated
glycan strand shifts within the cleft so that the new reducing end
is positioned in the active site again [90]. E. coli PBP1B strongly
prefers acceptor molecules with a lipid moiety while the donor
substrate requires both GlcNAc and MurNAc but no lipid
residue. This indicates that the mechanism of glycan chain
elongation by E. coli PBP1B is the same as for S. aureus PBP2
and A. aeolicus PBP1A [91]. An overview about the trans-
glycosylation step and its inhibition by antibiotics is given in a
recent review by Welzel [92].
Cross-linking of the peptides occurs by transpeptidation
between the D-Ala at position 4 of the donor peptide and the m-
A2pm residue at position 3 of the acceptor peptide. The energy
for this reaction is gained from the cleavage of the D-Ala–D-Ala
bond of the pentapeptide of the donor peptide. The active site
serine of motif I attacks the peptide bond between the two
terminal D-alanines of the donor to form an intermediary acyl-
enyzme complex which is cleaved by the ε-NH2-group of the
m-A2pm residue of the acceptor peptide to release the enzyme
and form the cross-link [49]. The crystal structure of the TP
domain of the class A PBP1B of S. pneumoniae has been solved
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domain [93]. Interestingly, in the absence of an antibiotic the
enzyme assumes a closed conformation with a blocked active
site. The presence of substrate results in an opening of the
catalytic gorge with an elongated binding cleft.
7.2. In vitro murein synthesis studies
To study murein synthesis in vitro turned out to be a
challenging task for several reasons. Firstly, the enzymes are
membrane-bound, of low cellular abundances and some of them
are intrinsically unstable. Secondly, the substrate lipid II has long
been a limiting factor until recently a newmethodwas developed
to produce larger amounts [94]. And thirdly, the analysis of the
synthesized murein requires particular analytical techniques.
Murein synthesis studies have been performed in vitro since the
late 1960s, either with isolated cell membranes [52,69,95–98],
ether-permeabilized cells [99], or proteins which had been
purified under denaturing conditions followed by renaturation
[100–102]. Later the proteins were specifically produced with a
tag and purified by affinity chromatography [49]. As substrate,
either UDP-MurNAc-pentapeptide and UDP-GlcNAc were
added to the membrane preparations [52,95–99,102–104], or
lipid II was added to the purified proteins [49,100,101]. Reaction
products were analyzed by paper chromatography.
We have recently developed a simple in vitro murein
synthesis assay based on the detection and analysis of the
reaction products formed from radioactively labeled lipid II by
high-pressure liquid chromatography (HPLC) [105]. Interest-
ingly, the activities of PBP1B, and in particular of the TP
reaction, are highest at conditions favoring dimerisation of the
enzyme (see below). Further, time-course experiments showedFig. 4. Murein synthesis reactions catalyzed by PBP1B in vitro. PBP1B elonga
transpeptidation (TP). Grey bars, MurNAc; white bars, GlcNAc; zigzag line, undecthat in the presence of lipid II both TP and TG reactions occur
simultaneously, suggesting that a dimer of PBP1B may produce
two glycan strands and simultaneously cross-link the peptides
between them (Fig. 4). Also, when the available lipid II was
consumed, peptide cross-linking occurred at a rate 12-fold lower
than the initial cross-linking rate. At optimum reaction con-
ditions, PBP1B is capable of converting lipid II in vitro to
murein with an average length of the glycan strands of about 25
disaccharide units, with almost 50% of the peptides being part of
cross-links. PBP1B not only produces dimeric, but to a lower
extent trimeric peptide structures, which result from a cross-
linking reaction between a dimeric and a monomeric peptide.
Furthermore, PBP1B is able to use artificial tri-, tetra-, and
pentapeptide compounds (present as UDP-linked precursors) as
acceptors for the TP reaction. Such reactions were observed
before in ether-treated cells and cell membrane preparations of
E. coli [99,104]. Kinetic studies of the TG-activity of the full-
length PBP1B protein [49] as well as of two truncated forms
L433b and S409 have shown that the kinetic efficiency (kcat/Km)
of the full-length protein is 4 to 5 fold higher than the one of the
truncated forms indicating that the TP domain may influence the
turnover rate of the TG-domain [47].
PBP1A with lipid II as a substrate produces in vitro murein
with an average length of 20 disaccharide units with about 20%
of peptides being part of cross-links [53]. PBP1A has poor TP
activity in the absence of transglycosylation (i.e. after lipid II
substrate is consumed). The TP activity of PBP1Awith lipid II is
also greatly reduced in a variant with inactive TG domain.
Furthermore, TP reactions are not detected when two PBP1A
variants, one with inactive TP domain and the other with inactive
TG domain were mixed. Thus PBP1A requires ongoing
transglycosylation reactions in the same molecule for thetes the glycan chains by transglycosylation (TG) and forms cross-links by
aprenyl residue; black circle, phosphate group.
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been observed before for other class A PBPs and points to a
probable intra-molecular activation mechanism involving inter-
actions between the TG and TP domains [49,53,101,105]. Time-
course experiments revealed that PBP1A-catalyzed transpepti-
dation requires the presence of already polymerized glycan
strands (transglycosylation product), indicating that PBP1A
might prefer high-molecular weight murein as acceptor for
cross-linking reactions (Fig. 5). Interestingly, in vitro PBP1A is
able to attach a fraction of the new murein synthesized from
radioactive lipid II to isolated murein sacculi by transpeptidation
reactions. Attachment of new material to the existing sacculus
occurs in the growing cell but had not been demonstrated in vitro
before.
Two other synthases from E. coli have been reported to have
transglycosylase activity in vitro. The isolated MtgA produced
from lipid II glycan strands carrying un-cross-linked pentapep-
tides in vitro [63]. Early reports identified both TG and TP
activities of PBP3 from E. coli [79], this was later shown to be a
monofunctional transpeptidase [83]. It is possible that the PBP3
preparation used in the early study contained contaminating
PBP1B, because both proteins were shown to interact with each
other (see below). The in vitro activities of PBP2, PBP3 and
PBP1C need to be characterized in future.Fig. 5. Murein synthesis reactions catalyzed by PBP1A in vitro. (A) PBP1A initially
only later, presumably with glycan strands carrying monomeric peptides as acceptors
to isolated sacculi in vitro by transpeptidation reactions. Grey bars, MurNAc; white8. The E. coli murein hydrolases
Murein hydrolases are enzymes that cleave covalent bonds in
murein or murein fragments [106]. Autolysins are, by virtue of
their enzymatic specificities and their periplasmic localization,
capable to digest the murein sacculus to small, soluble fragments
(Fig. 6). Muramidases, e.g. lysozyme, hydrolyze the β1,4-bond
between MurNAc and GlcNAc in the murein glycan strands.
Unlike lysozyme, lytic transglycosylases are muramidases
which cleave the glycosidic linkage with the concomitant
formation of a 1,6-anhydro bond at theMurNAc residue [3] (Fig.
6B). E. coli has six known lytic transglycosylases, with five
being lipoproteins residing in the outer membrane (MltA, MltB,
MltC, MltD, and EmtA) and facing into the periplasm, and one
being soluble (Slt70) (Table 3). EmtA is an endo-specific lytic
transglycosylase, whereas Slt70, MltA and MltB are exo-
enzymes that remove disaccharide units presumably from the
1,6-anhydroMurNAc glycan strand end. Other autolysins cleave
either the bond between the glycan strands and the peptides (the
N-acetylmuramyl-L-alanine amidases AmiA, AmiB and AmiC)
or hydrolyze peptide bridges (the DD- and/or LD-endopepti-
dases MepA, PBP4 and PBP7). Obviously, the activities of these
autolysins can destroy the integrity of the sacculus, and they
must be strictly controlled in the cell to avoid autolysis. Table 3forms an uncross-linked product with lipid II substrate. Cross-links are formed
(scheme II). (B) PBP1A is capable of attaching newly formed oligomeric murein
bars, GlcNAc; zigzag line, undecaprenyl residue; black circle, phosphate group.
Fig. 5 (continued).
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available structures [107–114].
The periplasmic murein hydrolases are quite active during
growth and division of the cell. In one generation, an E. coli cell
loses 40 to 50% of its total murein by the activity of hydrolases
[115,116]. This is a surprisingly high turnover rate, considering
the mainly single-layered architecture of murein and the need to
constantly maintain the integrity of the sacculus. The chemical
structures of the turnover products indicate that all autolytic
activities – lytic transglycosylases, N-acetylmuramyl-L-alanine
amidases and endopeptidases – participate in murein turnover.
This is particularly true for the cleavage of the division septum
where the amidases and also the lytic transglycosylases and the
endopeptidase PBP4 are required to allow cell separation [117–
119]. For example, a mutant lacking three amidases and the
soluble lytic transglycosylase Slt70 grows in chains of up to 40
non-separated cells. Also it has been shown that the amidase
AmiC localizes at the site of septation, whereas AmiA is
dispersed throughout the periplasm [120]. Analysis of these
chaining mutants lacking murein hydrolases has also shown thatthe permeability of the outer membrane is increased for
unknown reasons [118,121].
Only a minor fraction of the murein fragments released by
the hydrolases is lost into the growth medium because E. coli
has an efficient uptake and recycling system for murein turnover
products. Uptake from the periplasm into the cytoplasm occurs
via the unspecific oligopeptide permease Opp and the murein
peptide permease Mpp. Once taken up, different cytoplasmic
enzymes hydrolyze the murein fragments to compounds that
can re-enter the biosynthetic pathway of murein precursors
[122]. Interestingly, some Gram-negative bacteria, e.g. Citro-
bacter freundii and Enterobacter cloacae, elegantly couple
murein turnover with signaling for the production of chromo-
somally encoded β-lactamase, an enzyme that is secreted to
degrade exogenous β-lactam antibiotics [123]. The inhibition of
murein synthesis by β-lactams causes an uncontrolled activity
of autolytic enzymes which is characterized by a sudden
increase in murein turnover products that are taken up into the
cytoplasm. A transcriptional activator, AmpR, is inactivated by
the binding of murein precursor UDP-MurNAc pentapeptide,
Fig. 6. (A) Cleavage sites of the murein hydrolases. Ami, N-Acetylmuramyl-L-alanine amidase; LTase, lytic transglycosylase; DD-EPase, DD-endopeptidase; LD-
EPase, LD-endopeptidase; DD-CPase, DD-carboxypeptidase, LD-CPase, LD-carboxypeptidase. (B) Reaction of the lytic transglycosylases. R, peptide.
1725W. Vollmer, U. Bertsche / Biochimica et Biophysica Acta 1778 (2008) 1714–1734but becomes activated by binding a turnover product 1,6-
anhydroMurNAc-tripeptide, leading to the expression of AmpC
β-lactamase. Mutants without lytic transglycosylases (that
produce the 1,6-anhydroMurNAc compounds) or without the
permeases required for the uptake of turnover products, fail to
induce β-lactamase and lyse in the presence of exogenous β-
lactam antibiotic [121].
Carboxypeptidases are capable of removing the terminal
amino acid residues from the peptides in the murein. The
function of these enzymes is not yet clear since there are species,
e.g. C. crescentus, which appear to lack these activities [7]. On
the other hand, the DD-carboxypeptidase PBP5 has been im-
plicated in a regulatory function in murein synthesis in E. colibecause mutants lacking PBP5 show remarkable morphological
defects, including kinks, bends and even branches [124]. These
effects are exacerbated if additional PBPs are deleted, but the
normal rod-shaped cell morphology can always be restored by
the production of PBP5 from a plasmid-born dacA gene in these
multiple mutants [125]. The branches can arise either from de
novo generation of poles on the side wall or from splitting of an
existing pole by areas of activemurein synthesis [126]. The tip of
the deformed regions behave likemisplaced, fully functional cell
poles [127]. The combination of dacA deletion with certain ftsZ
(ts) mutations results – at restrictive temperature – in E. coli
cells with a helical cell shape [128]. The molecular mechanism
(s) by which PBP5 contributes to maintenance of rod-shape and
Table 3
Murein hydrolases of E. coli
Enzyme Specificity a MWb
[Da]
Gene Intracellular localization Function/remarks Reference for
structure
Slt70 LT 73,353 sltY Periplasm [112]
MltA LT 40,411 mltA Outer membrane Lipoprotein [114]
MltB LT 40,256 mltB Outer membrane Lipoprotein, degradation to Slt35 [113]
MltC LT 40,113 mltC Outer membrane Lipoprotein
MltD LT 49,417 mltD Outer membrane Lipoprotein [107]
EmtA c LT 26,575 emtA(mltE) Outer membrane Lipoprotein
AmiA Ami 31,412 amiA Periplasm Cell separation
AmiB Ami 47,985 amiB Periplasm Cell separation
AmiC Ami 45,634 amiC Periplasm, septation site Cell separation
AmpD 1,6Ami 20,536 ampD Cytoplasm Recycling [109]
PBP4 DD-EP/CP 51,798 dacB Periplasm, membrane d [108]
PBP7 DD-EP 34,245 pbpG Periplasm, membraned Proteolytic cleavage to PBP8
MepA DD/LD-EP 30,137 mepA Periplasm [110]
NagZ GA 37,595 nagZ (ycfO) Cytoplasm Recycling
PBP5 DD-CP 44,444 dacA Inner membrane Cell shape maintenance [111]
PBP6 DD-CP 43,609 dacC Inner membrane
PBP6B DD-CP 43,346 dacD Inner membrane
LdcA LD-CP 33,567 ldcA (ycgQ) Cytoplasm Recycling, essential in stationary phase
EnvC Unknowne 46,595 envC (yibP) Septation site Cell separation
FlgJ Unknown f 34,475 flgJ Flagellum Fagellum synthesis
a LT, lytic transglycosylase; Ami, N-acetylmuramyl-L-alanine amidase; 1,6Ami, 1,6-anhydro-N-acetylmuramyl-L-alanine amidase; GA, N-acetylglucosaminidase;
DD-EP, DD-endopeptidase; LD-EP, LD-endopeptidase; DD-CP, DD-carboxypeptidase, LD–CP, LD-carboxypeptidase.
b Molecular weights are given for the unprocessed form.
c Endo-specific lytic transglycosylase.
d Membrane-associated.
e Hypothetical peptidase.
f Hypothetical muramidase.
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rod-shape in the absence of PBP5 are not known.
9. Interactions between murein synthases and hydrolases
Because of its network-like structure the enlargement of the
sacculus requires not only synthetic reactions, but also hydro-
lysis of covalent bonds within the sacculus to allow
incorporation of subunits into the stress-bearing layer. It has
been proposed by Höltje that synthetic and hydrolytic re-
actions need to be coordinated temporarily and spatially for a
safe enlargement of the sacculus. He suggested that this is
achieved by the formation of multi-enzyme complexes com-
bining different murein synthases and hydrolases thus ensuring
that the hydrolases are active only at sites of new synthesis
[129–131].
Both the high murein turnover rate caused by hydrolases
during growth and the observed lytic effect upon inhibition of
murein synthesis in growing cells indicate a close functional
relationship between murein synthases and hydrolases. In E. coli
the hydrolases do not only cause lysis of already dead cells (as,
for example, the LytA autolysin in S. pneumoniae), but they are
highly active during cell growth. Genetic evidence for this close
functional connection between the synthase PBP1B and lytic
transglycosylases was obtained by the overproduction of PBP1B
variants with inactive catalytic domains (either TG or TP or
both). Both caused cell lysis in the wild-type strain but not in
mutants lacking the activities of the lytic transglycosylases
[132]. An explanation for this might be that PBP1B and lytictransglycosylases are part of (a) multi-enzyme complex(s).
Overproduction of inactive variants of PBP1B would then result
in the formation of complexes with defects in the synthetic part
but fully active hydrolysis sub-complexes, resulting in cell lysis.
Similarly, it has been shown that the overproduction of an
inactive variant of PBP3 results in filamentation, which is the
same phenotype as observed in cells lacking PBP3 activity
[133]. It is probable that the inactive PBP3 variants may replace
active enzyme from the cell division complex resulting in a
block in division. The differences in response upon over-
production of either inactive PBP1B or inactive PBP3 are likely
to be caused by their different roles in cell wall synthesis. While
the activity of PBP3 is restricted to murein synthesis during cell
division, PBP1B is likely active during both, elongation and
division. Therefore, overproduction of inactive PBP3 results in a
block of cell division, whereas overproduction of inactive
PBP1B affects both cell elongation and division, a condition that
is known to result in lysis.
Various interactions between different murein synthases,
synthases and hydrolases, and synthases and other proteins have
been detected and characterized in the recent years using genetic
and biochemical methods. PBP1B forms dimers which bind
more strongly to the cell envelope than the monomers. The
interaction site was localized to the N-terminal half of the
protein in front of G405 [44]. Part of the PBP1B-dimers of the
cell can be cross-linked to the murein, while others stay
associated with the inner membrane [134]. Disulfide bridges are
not involved in this dimerisation, as a PBP1B variant without
cysteine residues is fully functioning and able to form dimers
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heterodimers formed by PBP1A and PBP1B [43].
A number of affinity chromatography experiments with
immobilized murein enzymes led to the identification of several
direct and/or indirect interactions. Immobilized Slt70 retains
PBP1B, PBP1C, PBP2, PBP3 as well as the hydrolase PBP7/8
from crude membrane extract, whereas immobilized MltB
specifically binds PBP1B, PBP1C and PBP3 [135,136]. Im-
mobilized MltA retains the murein synthases PBP1B, PBP1C,
PBP2, and PBP3 as well as non-PBP proteins [137]. One of these
non-PBP-proteins was identified as a structural protein mediat-
ing the interaction between MltA and PBP1B, and was therefore
named MipA (MltA interacting protein A). A trimeric protein
complex containing PBP1B, MipA and MltA could be re-
constituted in vitro on a sensor chip for surface plasmon
resonance (BIAcore). If the membrane fraction was supplemen-
ted with periplasmic proteins, PBP1A is retained on the MltA-
column, indicating that the binding of PBP1A to MltA is
mediated by a so far unknown periplasmic factor. In other work it
was shown that immobilized PBP1C specifically retainsMltA as
well as the murein synthases PBP1B, PBP2 and PBP3 [45].
The interaction between PBP1B and PBP3 was demonstrated
by different in vivo and in vitro methods [138]. Firstly, im-
mobilized PBP3 retains PBP1B from crude membrane extract in
an affinity chromatography experiment. A direct interaction
between the purified enzymes was then shown by surface
plasmon resonance using a sensor chip with immobilized PBP3.
This interaction was shown to exist in vivo by the bacterial two-
hybrid system, which, in addition, revealed, that the first 56
amino acids of PBP3 are sufficient for the interaction with
PBP1B. PBP1B and PBP3 can be cross-linked in vivo and co-
immunoprecipitated with either an anti-PBP1B or an anti-PBP3
antibody. The interaction between PBP1B and PBP3 is
independent of the activity or the correct localization of PBP3.
The latter suggests that both proteins interact with each other
before PBP3 gets recruited to the cell division site. Consistent
with these results is the finding that only a proportion of PBP1B
localizes at mid-cell and that this is dependent on the presence
but not the activity of PBP3. The dissociation constants of the
interactions between murein synthases and hydrolases deter-
mined by surface plasmon resonance are given in Table 4.
Interactions between class A and class B PBPs were reported
for other bacteria. For example, β-lactam resistance of S. aureus
is mediated by a functional interaction between the TG activity
of PBP2 (class A) and the TP activity of PBP2A (class B) [139].
Only in the presence of PBP2A a β-lactam-inactivated PBP2 isTable 4
Dissociation constants determined by surface plasmon resonance
Interaction KD [M] Reference
PBP1B–PBP1B (1.27±0.96)×10−7 [105]
PBP1B–PBP3 a (9.56±3.13)×10−8 [135]
(4.35±0.21)×10−7
PBP1B–MipA (2.09±0.60)×10−6 [134]
PBP1B–(MipA+MltA) (8.50±0.57)×10−7 [134]
MipA–MltA (3.20±0.05)×10−7 [134]
a Interaction with two dissociation constants.able to localize correctly at the cell division site [140]. In
B. subtilis, the septal localization of PBP1 (class A) depends on
the presence of PBP2b (class B) [141]. In Enterococcus
faecalis, β-lactam resistance is mediated by PBP5 (class B)
only if PBPF (class A) is active [142]. Cross-linking of proteins
in H. influenzae cells revealed the existence of two different
high-molecular-weight complexes containing class A and class
B PBPs [143]. And finally, in C. crescentus several PBPs,
probably PBP1a, PBP2a, PBP2b and PBP3a, co-immunopre-
cipitated with PBP2 [144].
10. Interactions of murein synthases with cell cycle proteins
PBP3 had a different affinity to cephalexin when labeled
either in cells with or without ongoing cell division, and it was
concluded that the transpeptidase function of PBP3 was
activated in dividing cells by allosteric interactions or substrate
binding [145]. PBP3 and PBP1B are likely part of a murein
synthesis complex active at the cell division site and interact with
other proteins of the divisome [146]. FtsZ is the bacterial
homolog of tubulin and forms at mid-cell a ring-like, contractile
structure to which more than 12 other cell division proteins
assemble. The mature divisome is assembled in two steps [147],
with the cell division proteins FtsZ, FtsA, ZipA, FtsE, FtsX, and
FtsK localizing early in the cell cycle at mid-cell. Later, FtsQ,
FtsL, FtsB, FtsW, PBP3 (presumably together with PBP1B) and
FtsN are recruited to form the mature divisome. The integral
membrane protein FtsW is required for septal localization of
PBP3 [148], and a periplasmic loop between transmembrane
helices 9 and 10 in FtsW was found to be essential for
recruitment of PBP3 [149]. PBP3 itself was found to be required
for proper localization of FtsN [150], an essential cell division
protein which harbors a periplasmic murein-binding domain of
unknown function [151,152]. Indeed, the use of the bacterial two
hybrid system indicated interactions of PBP3 with FtsW and
FtsN, in addition to further interactions with itself (dimerisa-
tion), FtsA, FtsK, FtsL, FtsQ and YmgF [153,154]. Bacterial
two-hybrid experiments with truncated forms of PBP3 showed
different interaction sites for various proteins. The interaction
between PBP3 and FtsQ is mediated by amino acids 19 to 51 in
PBP3 [154] and amino acids 50 to 135 in FtsQ [155]. For the
interaction with FtsL the N-terminal part of PBP3 extending up
to amino acid 250 is required, while the interaction with FtsW
requires only amino acids 1 to 70 [154]. Several amino acids of
the nPB domain (G57, S61, L62, and R210) of PBP3 are
involved in the interaction with other proteins, possibly FtsN.
Residues V86, R141, and G188 in PBP3 are important to recruit
FtsN to the septation site [86]. These results show that PBP3
interacts with several components of the divisome.
Cell elongation of most rod-shaped species requires the
presence of the actin-like MreB which forms helical filaments
coiling around the length of the cell underneath the cytoplasmic
membrane [156]. Cells without MreB, or cells in which the
formation of theMreB spiral is blocked by the A22 inhibitor lose
their rod-shape and eventually lyse, similar to mutants lacking
PBP2. A fluorescent derivative of vancomycin, presumably
labeling murein precursor molecules and newly synthesized
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cells, dependent on the presence of the helically arranged
filaments of the MreB-homolog Mbl. Therefore, it was
suggested that the intracellular cytoskeleton elements may direct
the murein synthesis to maintain rod-shape during growth [157].
Another study used fluorescent ramoplanin or vancomycin to
label B. subtilis cells showing similar helical patterns which,
however, did not depend on the presence of Mbl [158]. The
reason for these conflicting results are unclear. The membrane
proteins MreC and MreD might couple the cytoplasmic MreB
filament with the periplasmic murein synthases [159]. In E. coli,
MreB forms a membrane-bound complex with MreC andMreD,
and the formation of intracellular MreB-filaments depends on
the presence of MreC, MreD and RodA [160]. MreC has a
membrane-anchor and a major periplasmic domain and was
shown to form homodimers [161]. In C. crescentus, MreB and
MreC form helices which do not co-localize, and the localization
of MreC is independent of MreB, indicating that in this species
there might not be a direct interaction between both proteins
[162]. In an affinity chromatography experiment, immobilized
MreC from C. crescentus was found to retain all murein
synthases (PBP1A, PBP1B, PBP2A, PBP2B and PBP2) from a
membrane fraction [163], and similarly, bacterial two hybrid
system shows interactions betweenMreC from B. subtilis and all
high-molecular weight PBPs of this bacterium [161].
11. Models for the growth of the murein sacculus in
Gram-negative bacteria
Several models for the growth of the sacculus during
elongation and division were proposed. According to most of
these models the enlargement of the sacculus is achieved by the
insertion of new glycan strands into the existing murein layer,
and the synthesis of new murein and hydrolysis of bonds, are
combined. The authors of the scaffold model (with a vertical
arrangement of the glycan strands relative to the membrane)
have presented a growth model which does not include any
enlargement of the surface of the murein [164]. For the safe
enlargement of the stress-bearing murein layer, Koch proposed,
that first new covalent bonds have to be formed before
hydrolysis of other bonds in the murein net takes place
(‘make-before-break’ strategy) [30].
In the growth model of Burman and Park, local hydrolysis of
cross-links by murein hydrolases precedes the incorporation of a
newly synthesized glycan strand that becomes cross-linked to
the neighboring strands in the existing murein layer [165,166].
Initially, cross-links are formed only between old and new
material, but after a while, new glycan strands are inserted next
to strands that were incorporated briefly before, resulting in
cross-links between two new peptides. This model does not
follow the ‘make-before-break’ strategy and it does not explain
the observed murein turnover (the release of fragments from the
sacculus during growth). It was proposed by Park, that murein
turnover is a process of its own for sensing the structure of the
sacculus [167].
According to the ‘three-for-one’ growth model, proposed by
Höltje, three new glycan strands are attached in a relaxedconformation underneath one glycan strand (‘docking’ strand) in
the sacculus [129,131]. Simultaneous removal of the docking
strand allows the insertion of the new triplet into the sacculus, by
this increasing its surface. During elongation, the middle strand
of the new triplet would be pre-formed by a monofunctional
transglycosylase, whereas during cell division, all three glycan
strands would be synthesized simultaneously. The ‘three-for-
one’ growth model explains the existence of a minor fraction of
trimeric cross-links with a short half-life (these are the
attachment sites of the new glycan strand triplet) and the
significant degree of murein turnover (the removal of the
docking strands), and it is in accordance with the ‘make-before-
break’ strategy. If the glycan strands run perpendicular to the
long axis of the cell, the diameter of the cell would remain
constant if the inserted triplet has the same length as the removed
docking strand. Also, if every second strand at the cylindrical
part of the sacculus could serve as a docking strand, the length of
the cell would exactly double in one generation. Höltje
suggested a molecular mechanism for the removal of every
second strand which involves DD- and LD-carboxypeptidase
activities (catalyzed by PBP5, PBP6 and PBP6B). Höltje has
also proposed that all enzymatic activities are coordinated by the
formation of multi-enzyme complexes consisting of different
murein synthases and hydrolases. This would then allow for
murein synthesis multi-enzyme complexes that are specialized
for certain functions, for example for cell elongation (with
PBP2) or in cell division (with PBP3).
12. Regulation of cell wall growth by cytoskeleton elements
Morphogenesis of E. coli seems rather simple with two
phases in the cell cycle [168,169]. During elongation, the cell is
enlarged by growth of the envelope along the cylindrical part
with maintenance of a constant diameter. Once the length of the
cell has doubled, there is a switch to a focused envelope
synthesis at the site of septation for the synthesis of the new polar
caps of the daughter cells.
Vancomycin-labeling of lipid II and nascent murein has been
used in B. subtilis to localize the sites of new murein synthesis
[157]. This method is not applicable for the Gram-negative
E. coli because the outer membrane prevents access of the
antibiotic to its binding sites. The topography of the enlargement
of the sacculus of E. coli has been studied by in vivo labeling of
murein with radioactive precursor, followed by high-resolution
autoradiography of the isolated sacculi by electron microscopy
[170]. An easier method with higher resolution is based on the in
vivo incorporation of exogenous D-cysteine into murein by a yet
unknown periplasmic enzyme, followed by biotinylation and
immunodetection of the label by electron (or fluorescence)
microscopy [171]. Pulse and pulse-chase experiments revealed
that a focused murein synthesis takes place at the septation site
during division. During cell elongation in the absence of
exogenous D-cysteine, the label is diluted at the cylindrical part
of the sacculus, indicating that new material is incorporated into
the existing side wall. While there are areas of homogenous
incorporation of new material into the sidewall, there appear to
exist also patches and arcs of entirely new material [172]. At the
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old murein (turnover), even during long chase periods. These
results on the murein segregation pattern are consistent with the
observations that during elongation new cross-links are formed
in the sacculus mainly between newly synthesized and old
(already existing) material, whereas during cell division there is
also cross-linkage between two newly made peptides [166,173].
The segregation pattern of the outer membrane is similar to that
of the murein layer, indicating that the enlargement of both
layers is coordinated [174]. Recent application of the D-cysteine
labeling method in C. crescentus revealed a murein segregation
pattern different to that in E. coli [175]. During the transition of
the swarmer to the stalked cell there is initially a diffuse
incorporation of new material into the side-wall. Unlike in E.
coli, murein growth is re-located to the future division site early
in the cell cycle andwell before a constriction is visible, resulting
in a preseptal growth from mid-cell for cell elongation. Mid-cell
growth continues during the following constriction to form the
new polar caps of the daughter cells. Interestingly, the
appearance of the growth zone for cell elongation at mid-cell
is dependent on the localization of FtsZ atmid-cell. Furthermore,
MurG which synthesizes the lipid II precursor, localizes at mid-
cell in an FtsZ-dependent way. Thus, FtsZ may have a function
not only in cell division but also in cell elongation, which
involves the localization of enzymes for lipid II synthesis. FtsZ-
dependent preseptal growth is not observed in wild-type E. coli
cells but in filamentous cells unable to constrict due to the lack of
functional PBP3 [171]. An enhanced, penicillin-insensitive and
PBP3-independent peptidoglycan synthesis activity has been
reported at mid-cell before E. coli cells start septation, and it was
named PIPS (penicillin-insensitive peptidoglycan synthesis)
[176,177]. Although the molecular basis for this observation hasFig. 7. Model for the temporal and spatial organisation of cytoskeleton elements a
elongate by a ‘dispersed’ incorporation of precursors by elongation-specific murein
dotted line). Formation of the FtsZ-ring (together with other early cell division prote
preseptal elongation at mid-cell. Constriction begins once the elongation complexe
synthesis complexes (blue circles). The lower part shows the composition of the subremained unclear it was proposed that PBP2 might be involved
[147]. Inhibition of FtsZ or production of an unstable FtsZ has
severe effects on cell shape in certain mutants lacking PBP5,
PBP4 and PBP7 (or certain combinations) with an increased
percentage of pentapeptides in their murein [178,179]. These
cells form branches or even grow in spiral-form. A recent study
followed up this phenomenon and showed that, in these mutants,
FtsZ contributes to the enlargement of the sacculus at non-mid-
cell positions [178]. It is not yet clear whether the effect of FtsZ
on murein synthesis away from mid-cell is relevant in wild-type
cells, or whether it is the result of an imbalance between cell
division and elongation systems in these mutants. In any case,
these interesting results show that FtsZ has the potential to direct
murein synthesis not only at mid-cell but also at other positions.
The gene order in the dcw gene cluster encoding for enzymes
for peptidoglycan precursor synthesis and cell division proteins
is conserved in rod-shaped bacteria [180]. Based on this
observation, the model of genomic channeling has been
proposed according to which there is a selective pressure to
maintain the cluster to efficiently coordinate the processes of cell
elongation and cell division [181]. The proposed mechanism
includes (i) the limitation in the amount of peptidoglycan
precursor, (ii) the co-translational assembly of complexes of cell
division proteins and enzymes for murein precursor synthesis,
and (iii) the alternation in cellular localization of the complexes
to participate in murein synthesis either at the lateral wall or at
the division site. In addition, the conservation of the dcw cluster
could be required tomaintain an optimum ratio of the numbers of
molecules per cell of cell division proteins and peptidoglycan
percursor synthesis enzymes.
Based on genetic studies, intracellular localization of proteins
and on the identification of protein–protein interactions a newnd murein synthesis complexes during the cell cycle. Upper part: Young cells
synthesis complexes (green circles) at filaments of the actin-like MreB (green
ins, blue dotted line) redirects the elongation complexes to mid-cell resulting in
s have been replaced from the FtsZ ring by the cell division-specific murein
-complexes for the different modes of growth.
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the recent years: Bacteria have a dynamic cytoskeleton which,
among other functions, directs (or regulates) cell wall growth
performed by murein synthesis multi-enzyme complexes
[131,182,183]. We could envision the following model for
cell wall growth during the cell cycle (Fig. 7): In newborn cells
membrane-bound multi-protein complexes for cell wall growth
are formed along the dynamic filaments of the actin-like MreB
protein. These complexes contain enzymes for precursor (lipid
II) synthesis (such as MraY and MurG), the cell elongation-
specific murein synthesis complex (with RodA, MreD, MreC,
PBP2 and, presumably, PBP1A), and the murein hydrolase
sub-complex (with lytic transglycosylases, amidases and/or
endopeptidases). During cell elongation, the cell wall synthesis
complex would either remain localized at the MreB filament to
use it as a track. Alternatively, the periplasmic sub-complexes
might assemble at the MreB filament and would then move
away from the filament for murein synthesis. This complex is
responsible for the incorporation of new material along the
side-wall by a ‘dispersed’ or ‘diffuse’ mode during cell
elongation. In young cells, the bacterial tubulin FtsZ appears
to rapidly oscillate on helical paths through the cytoplasm
[184]. Later in the cell cycle, FtsZ assembles together with
other early cell division proteins to a ring-like structure at mid-
cell. This happens well before a constriction is visible [147].
We propose that the localized, pre-divisional FtsZ-ring
‘captures’ the cell wall elongation machinery from the MreB
filament, redirecting murein growth to a zone at mid-cell. In E.
coli, this second, preseptal phase of cell elongation occurs only
during a short transition period between elongation and
constriction. In contrast, preseptal growth is much more
relevant in C. crescentus such that a large part of the sidewall
is synthesized by this mechanism [175]. The switch from
elongation to constriction requires remodeling of the complex.
Constriction starts once the division-specific murein synthesis
sub-complex (with FtsW, FtsQ, FtsL, FtsB, FtsN, PBP1B and
PBP3) has assembled and replaced the elongation complex
from the FtsZ ring. When septation progresses the multi-
protein ring operates at the leading edge of constriction to
attach new murein in ever smaller concentric circles. Once
division is completed, the FtsZ-ring complex disassembles and
murein growth is redirected to the MreB filaments to start
another elongation cycle. This model would be in accordance
with the earlier speculation that cell wall growth involves the
competition between two systems, one for elongation and
another for cell division [185]. Morphogenesis of non-spherical
bacteria might be driven by a competition between different
cytoskeleton elements for controlling the murein synthesis
multi-enzyme complexes.
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